Clinician-Friendly AI Enables Personalized Healthcare Discoveries in the Cloud
Ce communiqué n'est disponible que dans la langue dans laquelle il a été rédigé.
Cision, March 6, 2018 – Precision medicine is driving innovations in cancer therapy. Molecules are being designed to target specific genetic mutations and immunologic characteristics of a given tumor. However widespread adoption has been slow, in part to due to a lack of accessible testing for patients.